Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Sep 24, 2024, 00:05 |
Blog
Rahul Gosain: Amivantamab and Chemo now FDA approved in 2L mEGFR NSCLC after Osimertinib
Rahul Gosain posted on LinkedIn: "Amivantamab and Chemo now FDA approved in 2L mEGFR NSCLC…
Sep 23, 2024, 16:26 |
Blog
Tom Snow: The FDA approved our combination therapy for adults with newly diagnosed Multiple Myeloma
Olivier Nataf, Global Head of Oncology at Sanofi, shared a post by Tom Snow on…
Sep 23, 2024, 14:23 |
Blog
Tatiana Prowell: Ribociclib is now FDA-approved for stage 2 and 3 hormone receptor positive, HER2 negative breast cancer
Erika Hamilton shared on X by Tatiana Prowell, additing: ''Well isn't this a gift for…
Sep 23, 2024, 00:12 |
Insight
Elisa Agostinetto: FDA has approved adjuvant ribociclib based on the results of the NATALEE trial presented at ESMO24
Elisa Agostinetto shared a post by MediMix on LinkedIn, adding: “FDA has just approved adjuvant…
Sep 21, 2024, 00:03 |
Insight
Rami Manochakian: U.S. FDA approves Amivantamab + Chemotherapy for advanced EGFR+ NSCLC
Rami Manochakian shared a post on X: "Hot off the press. As expected (and already…
Sep 20, 2024, 13:27 |
Blog
Stephen V Liu: FDA approved MARIPOSA2
Stephen V Liu shared on X: “FDA approved MARIPOSA2: amivantamab plus chemotherapy for EGFR NSCLC…
Sep 19, 2024, 18:53 |
Insight
Thorvardur Halfdanarson: Cabozantinib in previously treated advanced NETs
Thorvardur Halfdanarson, Professor of Oncology at Mayo Clinic School of Medicine, shared a post on…
Sep 19, 2024, 14:24 |
Insight
Elisa Agostinetto: FDA has approved ribociclib with an AI for the adjuvant treatment of HR+/HER2-negative breast cancer
Elisa Agostinetto shared a post on X: “Novartis today announced that the FDA has approved…
Sep 19, 2024, 11:55 |
Insight
Aakash Desai: Efficacy, Innovation and Cost of FDA-Approved NSCLC Drugs
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: “We're excited to…
Sep 17, 2024, 16:06 |
Blog
Xiuning Le: BAY88 has received USA FDA and Chinese NMPA BTD status for pre-treated HER2-mutant NSCLC
Xiuning Le shared a post by Bayer Oncology on LinkedIn, adding: "BAY88 has received USA FDA and…
1
2
3
4
5
All:
934
Posts:
11 - 20
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube